Physics and AI Driven Precision Engineering of Novel Drugs
Company
Platform
Pipeline
News
Contact
Investors
Community
Health + Time : Priceless
We Engineer New Treatments Atom by Atom
To help you live healthier, longer
Your browser does not support the video tag.
For a range of major human diseases, we’re developing treatments that cannot be found through any other method
For a range of major human diseases, we’re developing treatments that cannot be found through any other method
Your browser does not support the video tag.
First-in-Class Drug Candidates
to Change the Standard of Care for Every Disease We Address
PREVENTING HEART ATTACKS & STROKES WITH LOWER BLEEDING RISK
to help
185.7M
patients
2 Candidates
VE-1902, VE-2851
Stage: Clinical
PREVENTING & TREATING DIABETIC VISION LOSS WITHOUT EYE INJECTIONS
to help
179M
patients
2 Candidates
VE-4840, VE-3539
Stage: IND-Prep
PROVIDING CHEMO AGENTS FOR MULTIDRUG-RESISTANT CANCERS
to help
10M
patients
2 Candidates
VE-4054, VE-4932
Stage: Preclinical
PREVENTING AGGRESSIVE SOLID-TUMOR CANCER METASTASIS
to help
9M
patients
2 Candidates
VE-2843, VE-1787
Stage: Optimization
RESTORING IMMUNE RESPONE TO CD73 POSITIVE CANCERS
to help
6.5M
patients
2 Candidates
VE-3771, VE-5953
Stage: Preclinical
+
Many More…
Previous
Next
More about our pipeline
Recent News
First-in-Class Drug Candidates
to Change the Standard of Care for Every Disease We Address
PREVENTING HEART ATTACKS & STROKES WITH LOWER BLEEDING RISK
to help
185.7M
patients
2 Candidates
VE-1902, VE-2851
Stage: Clinical
PREVENTING & TREATING DIABETIC VISION LOSS WITHOUT EYE INJECTIONS
to help
179M
patients
2 Candidates
VE-4840, VE-3539
Stage: IND-Prep
PROVIDING CHEMO AGENTS FOR MULTIDRUG-RESISTANT CANCERS
to help
10M
patients
2 Candidates
VE-4054, VE-4932
Stage: Preclinical
PREVENTING AGGRESSIVE SOLID-TUMOR CANCER METASTASIS
to help
9M
patients
2 Candidates
VE-2843, VE-1787
Stage: Optimization
RESTORING IMMUNE RESPONE TO CD73 POSITIVE CANCERS
to help
6.5M
patients
2 Candidates
VE-3771, VE-5953
Stage: Preclinical
+
Many More…
Previous
Next
More about our pipeline
Recent News
Our stories
How Organoids Will Impact Medicine
Verseon's Head of Discovery Biology Anirban Datta discusses how recent breakthroughs are bringing once-distant possibilities for drug discovery and restoration of organ function closer to reality
October 30, 2024
Forbes Highlights Verseon's Platform to Design Novel Drugs No One Else Can
"Verseon's disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine."
October 22, 2024
Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy
Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art
October 9, 2024
VersAI™ : Ensuring AI Accuracy When Data Is Sparse
Verseon’s newly developed technology elevates AI accuracy to a new level, overcoming the major challenge sparse data poses in drug discovery and many other fields
October 2, 2024
A Quiet Revolution: The Global Race to Control Human Biology and Its Implications
The United States is locked in a quiet but heated race for bioscience and biotechnology supremacy with China. It is a race that changes everything
September 30, 2024
Verseon: the Future of Drug Discovery
CEO Adityo Prakash discusses the impact of Verseon’s innovations in AI, physics, and drug discovery on the future of medicine
September 18, 2024
33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs
How new tech unlocks seemingly infinite chemical space
September 12, 2024
Announcing VersAI™ : Setting a New Standard for AI Accuracy
"Beyond drug discovery, VersAI's greater accuracy and lower error rates can dramatically improve the utility and reliability of AI in our everyday lives."
September 11, 2024
How Organoids Will Impact Medicine
Verseon's Head of Discovery Biology Anirban Datta discusses how recent breakthroughs are bringing once-distant possibilities for drug discovery and restoration of organ function closer to reality
October 30, 2024
Forbes Highlights Verseon's Platform to Design Novel Drugs No One Else Can
"Verseon's disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine."
October 22, 2024
Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy
Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art
October 9, 2024
VersAI™ : Ensuring AI Accuracy When Data Is Sparse
Verseon’s newly developed technology elevates AI accuracy to a new level, overcoming the major challenge sparse data poses in drug discovery and many other fields
October 2, 2024
A Quiet Revolution: The Global Race to Control Human Biology and Its Implications
The United States is locked in a quiet but heated race for bioscience and biotechnology supremacy with China. It is a race that changes everything
September 30, 2024
Verseon: the Future of Drug Discovery
CEO Adityo Prakash discusses the impact of Verseon’s innovations in AI, physics, and drug discovery on the future of medicine
September 18, 2024
33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs
How new tech unlocks seemingly infinite chemical space
September 12, 2024
Announcing VersAI™ : Setting a New Standard for AI Accuracy
"Beyond drug discovery, VersAI's greater accuracy and lower error rates can dramatically improve the utility and reliability of AI in our everyday lives."
September 11, 2024
More News
Our stories
How Organoids Will Impact Medicine
Verseon's Head of Discovery Biology Anirban Datta discusses how recent breakthroughs are bringing once-distant possibilities for drug discovery and restoration of organ function closer to reality
October 30, 2024
Forbes Highlights Verseon’s Platform to Design Novel Drugs No One Else Can
"Verseon's disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine."
October 22, 2024
Verseon Develops Superior Approach in Combining AI Models for Greater Accuracy
Peer-reviewed paper describes novel ensembling technique that offers 150% improvement over current state of the art
October 9, 2024
VersAI™ : Ensuring AI Accuracy When Data Is Sparse
Verseon’s newly developed technology elevates AI accuracy to a new level, overcoming the major challenge sparse data poses in drug discovery and many other fields
October 2, 2024
More News
Changing everything the world can expect from 21st Century Medicine
Continue to
Company
Your browser does not support the video tag.